Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beer

Showing results (671-680 of 888) with videos related to

Pageof 89
Sort By:
International Journal of Obesity (2005)|August 19, 2016
Perpetuating effects of androgen deficiency on insulin resistanceJ L Cameron, R Jain, M Rais, et al.
Urology|May 25, 2010
Acupuncture for hot flashes in patients with prostate cancerTomasz M Beer, Maria Benavides, Sandra L Emmons, et al.
Cancer|January 11, 2005
Phase II study of transdermal estradiol in androgen-independent prostate carcinomaLisa B Bland, Mark Garzotto, Thomas G DeLoughery, et al.
Journal of Lipid Research|November 22, 2005
Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancerJonathan Q Purnell, Lisa B Bland, Mark Garzotto, et al.
Cancer|December 19, 2007
A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxelRobert W Ross, Tomasz M Beer, Susanna Jacobus, et al.
Tumori|October 31, 1991
Carboplatin, continuous infusion fluorouracil and mid-cycle high-dose methotrexate as initial treatment in patients with locally advanced head and neck cancer. Hellenic Co-operative Oncology Group StudyG Fountzilas, P Kosmidis, P Makrantonakis, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1987
A phase II study of carboplatin in advanced or metastatic stomach cancerM Beer, F Cavalli, S B Kaye, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Pharmacokinetics of VP16-213 given by different administration methodsM D'Incalci, P Farina, C Sessa, et al.
The Journal of Urology|July 12, 2005
Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes StudyRobert A Stephenson, Motomi Mori, Yi-Ching Hsieh, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 29, 2016
Enzalutamide in Japanese patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer: A post-hoc analysis of the placebo-controlled PREVAIL trialGo Kimura, Junji Yonese, Takashi Fukagai, et al.
Pageof 89

Showing results (671-680 of 888) with videos related to

Sort By:
Pageof 89
International Journal of Obesity (2005)|August 19, 2016
Perpetuating effects of androgen deficiency on insulin resistanceJ L Cameron, R Jain, M Rais, et al.
Urology|May 25, 2010
Acupuncture for hot flashes in patients with prostate cancerTomasz M Beer, Maria Benavides, Sandra L Emmons, et al.
Cancer|January 11, 2005
Phase II study of transdermal estradiol in androgen-independent prostate carcinomaLisa B Bland, Mark Garzotto, Thomas G DeLoughery, et al.
Journal of Lipid Research|November 22, 2005
Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancerJonathan Q Purnell, Lisa B Bland, Mark Garzotto, et al.
Cancer|December 19, 2007
A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxelRobert W Ross, Tomasz M Beer, Susanna Jacobus, et al.
Tumori|October 31, 1991
Carboplatin, continuous infusion fluorouracil and mid-cycle high-dose methotrexate as initial treatment in patients with locally advanced head and neck cancer. Hellenic Co-operative Oncology Group StudyG Fountzilas, P Kosmidis, P Makrantonakis, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1987
A phase II study of carboplatin in advanced or metastatic stomach cancerM Beer, F Cavalli, S B Kaye, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Pharmacokinetics of VP16-213 given by different administration methodsM D'Incalci, P Farina, C Sessa, et al.
The Journal of Urology|July 12, 2005
Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes StudyRobert A Stephenson, Motomi Mori, Yi-Ching Hsieh, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 29, 2016
Enzalutamide in Japanese patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer: A post-hoc analysis of the placebo-controlled PREVAIL trialGo Kimura, Junji Yonese, Takashi Fukagai, et al.
Pageof 89